タンパク質発現の世界市場規模：用途別、製品別、地域別、範囲および予測

タンパク質発現の市場規模と予測

タンパク質発現市場の市場規模は、2021年に28億7,000万米ドルと評価され、2023年から2030年にかけて11.47%のCAGRで成長し、2030年には76億3,000万米ドルに達すると予測されています。この市場の成長は、慢性疾患の罹患率の上昇、老人人口の増加、タンパク質生物製剤の需要増加が主な要因です。新興国は、同市場のプレーヤーに大きな成長機会をもたらす可能性が高いです。世界のタンパク質発現市場レポートは、市場の全体的な評価を提供します。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界のタンパク質発現市場の定義

タンパク質発現とは、特定のタンパク質を生成するバイオテクノロジーのプロセスを指し、通常、組み換え遺伝子を大量に発現するように生物の遺伝子発現を操作することによって達成されます。遺伝子工学と組換え技術の開発により、研究、臨床、工業の目的で異種タンパク質を発現・単離する多くの可能性が開かれました。バイオテクノロジーの著しい進歩により、大規模な組換えタンパク質の発現と単離が可能になった。

重要な成果の一つは、細胞内に入ることができる組換えタンパク質の開発です。このような開発は、細胞内機構を標的にしたり、治療用タンパク質を用いて細胞内作動酵素を代替することにより、治療医学における全く新しい可能性をもたらすものです。最初に確立された発現プラットホームは、大腸菌による原核生物システムでした。その後、昆虫、酵母、藻類、哺乳類など他の発現系が開発されました。タンパク質の発現とは、生体内でタンパク質がどのように合成され、修飾され、制御されるかを指します。タンパク質発現は、バイオテクノロジーと製薬産業の範囲が拡大しているため、民間や政府のヘルスケア機関が主に投資しています。

タンパク質発現の世界市場概要

タンパク質発現は、研究、産業、治療などにおいて重要な用途を見出します。ペプチドホルモン、ワクチン、モノクローナル抗体、治療用酵素、抗体、血液因子、サイトカインなどの治療用タンパク質は、がん、糖尿病、多発性硬化症などの慢性疾患の治療に広く使用されています。これらのタンパク質は、生物製剤の生産において品質、精度、効率を高めています。

タンパク質発現市場の成長を後押しする要因には、老人人口の増加、加齢関連疾患、がんなどの慢性疾患の有病率の上昇などがあります。さらに、タンパク質研究への支出の増加も、タンパク質発現市場の成長を後押ししています。しかし、タンパク質製品の生産に関連する高額な資金投入が市場の成長を制限しています。さらに、訓練を受けた医療専門家の大幅な不足と現地の専門知識の不足も市場の抑制要因となっています。

質量分析、分子遺伝学、製造技術などの技術革新の改善は、タンパク質発現市場の重要な促進要因です。さらに、新興国市場におけるより優れた疾患検出、医療技術、医療の成長における急速な開発は、市場にプラスの影響を与えるはずです。

目次

第1章 世界のタンパク質発現市場：イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界のタンパク質発現市場の展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析
• 規制の枠組み

第5章 タンパク質発現の世界市場：製品別

• 概要
• 試薬
• 発現ベクター
• コンピテントセル
• 器具
• サービス

第6章 タンパク質発現の世界市場：用途別

• 概要
• 治療
• 産業
• 研究

第7章 タンパク質発現の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 世界のその他の地域

第8章 世界のタンパク質発現市場：競合情勢

• 概要
• 企業市場シェア
• ベンダー情勢
• 主な発展戦略

第9章 企業プロファイル

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Genscript Biotech Corporation
• Agilent Technologies, Inc.
• Takara Bio Inc.
• Promega Corporation
• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• Lonza Group Ltd.
• New England Biolabs Inc.

第10章 付録

• 関連レポート

Protein Expression Market Size And Forecast

Protein Expression Market size was valued at USD 2.87 Billion in 2021 and is projected to reach USD 7.63 Billion by 2030 , growing at a CAGR of 11.47% from 2023 to 2030. The growth of this market is driven majorly by the rising incidence of chronic diseases, growth in the geriatric population, and rising demand for protein biologics. Emerging economies are likely to create significant growth opportunities for players in the market. The Global Protein Expression Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Protein Expression Market Definition

Protein expression refers to a biotechnological process of generating specific proteins, typically attained by manipulating gene expression in an organism such that it expresses large amounts of a recombinant gene. The development of genetic engineering and recombinant technologies has opened many possibilities for expressing and isolating heterogonous proteins for research, clinical, and industrial purposes. Considerable advances in biotechnology have enabled the expression & isolation of recombinant proteins on a large scale.

One of the significant achievements is the development of recombinant proteins capable of entering a cell. Such developments lead to entirely new opportunities in therapeutic medicine by targeting intracellular mechanisms or by substituting intracellular operating enzymes through therapeutic proteins. The first expression platform established was the prokaryotic system through Escherichia coli. The development of other expression systems, including insects, yeast, algae, and mammals followed this. Protein expression refers to how proteins are synthesized, modified, and regulated in living organisms. Protein expression is majorly being invested in by private and Govt. healthcare bodies due to the increasing scope of biotechnology and pharmaceutical industries.

Global Protein Expression Market Overview

Protein expression finds significant application in research, industrial and therapeutics, and others. Therapeutic proteins such as peptide hormones, vaccines, monoclonal antibodies, therapeutic enzymes, antibodies, blood factors, and cytokines are widely used to treat chronic diseases such as cancer, diabetes, and multiple sclerosis. These proteins have elevated quality, accuracy, and efficiency in biologics production.

The factors that boost the Protein Expression Market growth include an increase in the geriatric population, age-related diseases, and a rise in the prevalence of chronic diseases such as cancer. Moreover, increased spending on protein research also fuels the growth of the Protein Expression Market. However, high monetary inputs associated with the production of protein products restrict the market's growth. In addition, a significant shortage of trained healthcare professionals and a lack of local expertise also restrains the market.

Improvements in innovations such as mass spectrometry, molecular genetics, and manufacturing techniques are critical drivers in the Protein Expression Market. Furthermore, rapid developments in better disease detection, medical technology, and healthcare growth in emerging markets should positively impact the market.

Global Protein Expression Market: Segmentation Analysis

The Global Protein Expression Market is Segmented on the basis of Application, Product, And Geography.

Protein Expression Market, By Product

• Reagents
• Expression Vectors
• Competent Cells
• Instruments
• Services

Based on Product, the market is bifurcated into Reagents, Expression vectors, competent cells, Instruments, and Services. The reagents segment was the largest revenue-grossing segment of the market due to the large application of these products for research and biopharmaceuticals manufacturing. The repetitive purchase of reagents for various applications including therapeutic, industrial, and research is expected to boost the market growth.

• The services segment is anticipated to witness the fastest growth rate during the study period due to the escalating trend of services for custom optimization of protein expression. In addition, the service providers are equipped with advanced products and research specialists, which is expected to propel the demand for protein expression services by manufacturers and research laboratories.

Protein Expression Market, By Application

• Therapeutic
• Industrial
• Research

Based on Application, the market is bifurcated into Therapeutic, Industrial, and Research. The therapeutic application segment dominated the overall sector in terms of revenue in 2016. This is due to the large application of protein expression for the production of biologics. These products provide high accuracy, efficiency, and quality in biologics production. This segment is also projected to grow at the highest rate during the forecast period owing to the growing popularity of therapeutic proteins over other drugs.

Protein Expression Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Based on regional analysis, the Global Flexible Substrates Market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific market is expected to grow at the highest CAGR during the forecast period, owing to the rising penetration of contract research organizations and developing healthcare infrastructure in Asian countries including India and China. The availability of a massive genome pool, a large number of patients, accessibility of skilled personnel, and less stringent regulation for biologics production in Asian countries have propelled the sector growth in this region.

Key Players

• The "Global Protein Expression Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Thermo Fisher Scientific Inc., Merck KGaA, Genscript Biotech Corporation, Agilent Technologies, Inc., Takara Bio Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Lonza Group Ltd., New England Biolabs Inc., Sengenics, Proteogenix, Synthetic Genomics Inc.
• These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PROTEIN EXPRESSION MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL PROTEIN EXPRESSION MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis
• 4.5 Regulatory Framework

5 GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Reagents
• 5.3 Expression Vectors
• 5.4 Competent Cells
• 5.5 Instruments
• 5.6 Services

6 GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Therapeutic
• 6.3 Industrial
• 6.4 Research

7 GLOBAL PROTEIN EXPRESSION MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Argentina
• 7.6 Rest of the World

8 GLOBAL PROTEIN EXPRESSION MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Share
• 8.3 Vendor Landscape
• 8.4 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Thermo Fisher Scientific Inc.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Merck KGaA
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Genscript Biotech Corporation
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Agilent Technologies, Inc.
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Takara Bio Inc.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Promega Corporation
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Bio-Rad Laboratories, Inc.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Qiagen N.V.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Lonza Group Ltd.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 New England Biolabs Inc.
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Reports